CLU and Alzheimer disease: In the current study, we focused our analysis on aMCI populations and aimed to investigate whether plasma levels of APL1β28 and clusterin are correlated with cognitive status in the aMCI population and whether these correlations have relationships with other risk factors associated with aMCI and AD.